ANNX

Conviction 14HealthcareScan · Thu, Sep 24, 2026

Annexon, Inc. (ANNX) closed at $3.80 (-1.81%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 29, RS Rating 76, -45.4% from its 52-week high, -19.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

ANNX$3.80-1.81%

ResistanceSupportVol 14Insider buy

Vol MA14 3.42M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Annexon, Inc.PHARMACEUTICAL PREPARATIONSwww.annexonbio.com ↗

Price3.80

Change-1.81%

Gap-0.52%

Rel volume1.27×

Avg volume3.03M

Avg $ vol13.05M

SMA 204.40

SMA 504.93

SMA 2005.38

Price vs 50-22.99%

Price vs 200-29.40%

MA stackbearish

50/200 cross—

Supertrenddown · 4.52

RSI (14)29

MACD hist-0.02

MACD cross—

Stoch %K / %D6 / 14

ADX (14)26

+DI / −DI15 / 33

RSI divergence—

MACD divergence—

ATR %6.65%

ADR %5.32%

52w high6.96

52w low2.68

From 52w high-45.40%

Above 52w low+41.79%

New 52w highNo

SqueezeOff

Bollinger width41.05%

%B0.17

Donchian pos4.70%

Donchian high5.32

Donchian low3.73

AVWAP (52w high)5.38

vs AVWAP high-29.40%

AVWAP (52w low)5.25

vs AVWAP low-27.60%

OBV trendDown

Chaikin MF (20)-0.18

Today vs 20d1.27×

Avg vol (14d)3.42M

Avg vol (20d)3.03M

Avg $ vol (20d)13.05M

Market cap146.54M

RS Rating76 / 99

RS 3m (vs SPY)-30.70%

RS 6m (vs SPY)-45.99%

RS line new highNo

Trend template2/8

Technical rank9.8

1 week-8.87%

1 month-26.21%

3 months-26.21%

6 months-29.17%

1 year+30.58%

YTD-18.98%

P/E-0.71

P/B0.79

P/S—

P/FCF-0.79

EPS-1.34

Div yield—

ROE-111.09%

ROA-84.00%

Debt/Eq—

Current5.53

EV/EBITDA0.25

Gross margin—

Net margin—

Rev growth—

EPS growth-49.56%

Price target13.23

Target upside248.16%

Analyst ratingBuy

Institutional98.38%

Ent. value-52.73M

Revenue—

Net income-55.35M

Gross profit—

Free cash flow-186.49M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out163.84M

Employees93

ListedFri, Jul 24, 2020

Free float86.06M

Float %71.9%

Short interest32.09M

Days to cover12.7d

Short volume66.9%

Squeeze score87 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.28 vs −$0.23

Last surprise-21.7% miss

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank9.8 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.65

Support4.30

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Breaking out now
Jul 15
1 scan
→
Setting up
Jul 16
1 scan

Congress activity

Disclosed STOCK Act trades in ANNX

All disclosures →

No recent disclosed trades by Congress in ANNX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ANNX · open-market 3 buys

Insider	Side	Shares	Value	Traded	Filed
Blumenkranz Mark S. Director · Stock Option (Right to Buy) · 2026-08-10	Grant	175K	—	2026-08-10	2026-08-12
Satter Muneer A Director · Common Stock · 2026-05-28	Buy	613.5K	$3.3M	2026-05-28	2026-05-29
Carson William H. Director · Common Stock · 2026-05-11	Buy	8K	$46K	2026-05-11	2026-05-13
Carson William H. Director · Common Stock · 2026-04-10	Buy	8K	$50K	2026-04-10	2026-04-14

SEC filings

EDGAR filings in ANNX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.